Диссертация (1174363), страница 27
Текст из файла (страница 27)
Med. Assoc. – 2008. – V 71(12). – P. 605-9.104.Chen, C.C. Early changes of serum proinflammatory and anti- inflammatory cytokines after en-doscopic retrograde cholangiopancreatography/ C.C. Chen, S. S. Wang, R.H. Lu, C. C. Lu,F.Y.Chang, S.D. Lee// Pancreas. – 2003. – V 26(4). – P. 375–380.105.Cheon, Y.K. Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predomi-nantly high-risk patients: a randomized double-blind prospective trial/ Y.K. Cheon, K.B. Cho, J.L.Watkins, L.
McHenry, E.L. Fogel, S. Sherman, S. Schmidt, L. Lazzell-Pannell, G.A. Lehman// Gastrointest Endosc. – 2007. – V 66 (6). – P. 1126–1132.106.Choudhary,A.Effectofprecutsphincterotomyonpost-endoscopicretrogradecholangiopancreatography pancreatitis: a systematic review and meta-analysis/ A. Choudhary, J.Winn, S. Siddique, M. Arif, Z. Arif , G.M. Hammoud , S.R. Puli, J.A. Ibdah, M.L. Bechtold// World JGastroenterol. - 2014. – N 20.
– P. 4093–4101.107.Choudhary, A. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review/ A. Choudhary, M.L. Bechtold, M. Arif, N.M. Szary, S.R. Puli, M.O.Othman, W.P. Pais, M.R. Antillon, P.K. Roy// Gastrointest Endosc. – 2011. – N 73. - P. 275–282.108.Christoforidis,E.related and operative riskPost-ERCPfactors/pancreatitisE. Christoforidis,I.andhyperamylasemia: patient-Goulimaris,I.Kanellos,K.Tsalis,C. Demetriades, D. Betsis// Endoscopy.- 2002.- V 34(4). – P. 286 - 92.109.Classen,M.Endoscopischesphinkterotomieund steinextraktion aus dem ductus choledochus/ M.derpapillavateriClassen, L. Demling// Dtsch. Med. Wschr.–1974. – N 99.
- P. 496-7.110.Cohen, S. National Institutes of Health state-of-the-science conference statement: ERCP fordiagnosis and therapy, January 14–16 2002/ S. Cohen, B.R. Bacon, J.A. Berlin, D. Fleischer, G.A.Hecht, P.J. Sr. Loehrer, A.E. Jr . McNair, M. Mulholland, N.J. Norton, L. Rabeneck, D.F. Ransohoff,A. Sonnenberg, M.W. Vannier// Gastrointest Endosc.
- 2002. – V 56 (6) -. P. 803–809.111.Complications of ERCP. Gudeline// Gastrointestinal endoscopy. – 2012. – V 75(3). – P. 467-473.112.Concepcion-Martin, M. Somatostatin for prevention of post-ERCP pancreatitis: a randomized,double-blindtrial/ M.Concepcion-Martin, C.Gomez-Oliva, A.Juanes, X.Diez, D.Prieto-121Alhambra, X. Torras, S. Sainz, C. Villanueva,A. Farre, C. Guarner-Argente,C. Guarner//Endoscopy.
– 2014. – V 46(10). – P. 851-6.113.Cooper. S.T. Incidence, risk factors, and prevention of post-ERCP pancreatitis. Gastroenterol/S.T. Cooper, A. Slivka// Clin. North. Am. – 2007. – V 36 (2). – P. 259–276.114.Coté, G.A. Difficult biliary cannulation: use of physician-controlled wire- guided cannulationover a pancreatic duct stent to reduce the rate of precut sphincterotomy (with video)/ G.A. Coté, M.Ansstas, R.Pawa, S.A.Edmundowicz, S.S.Jonnalagadda, D.K.Pleskow,R.R.
Azar//Gastrointest Endosc. – 2010. - V 71(2). – P. 275-9.115.Cotton, P.B. Endoscopic retrograde cholangiopancreatography: maximizing benefits and mini-mizing risks/ P.B. Cotton//Gastrointest. Endosc. Clin. N. Am. - 2012. – V 22 (3). – P. 587–599.116.Cotton, P.B. Endoscopic sphincterotomy complications and their management: an attempt atconsensus/ P.B. Cotton, G.
Lehman, J. Vennes, J.E. Geenen, R.C. Russell, W.C. Meyers, C. Liguory, N. Nickl// Gastrointest. Endosc. – 1991. - V 37 (3). – P. 383-393.117.Cotton, P.B. Risk factors for complications after ERCP: a multivariate analysis of 11,497 pro-cedures over 12 years/ P.B. Cotton, D.A. Garrow, J. Gallagher, J. Romagnuolo// Gastrointest. Endosc.- 2009.
– V 70 (1). – P. 80-88.118.Dai, H.F. Role of nonsteroidal anti- inflammatory drugs in the prevention of post-ERCPpancreatitis: a meta-analysis/ H.F. Dai, X.W. Wang, K. Zhao// Hepatobiliary Pancreat. Dis. Int. – 2009.– N 8. - P. 11–16.119.Dale, S. Comparison of three D-dimer assays for the diagnosis of DVT: ELISA, latex andan immunofiltration assay (NycoCard D-dimer)/ S. Dale, Gostad G.O., Brosstad F., H.C. Godal, J.Holtlund, E. Mork, O.
Brandsnes, S.M. Borch// Thromb Haemost. – 1994. - V 71(3). - P. 270-274.120.Dhingra, R. Single or multi part percutaneous endoscopic necrosectomy performed with thepatient under conscious sedation is a safe and effective treatment for infected pancreatic necrosis/R. Dhingra, S. Srivastava, S. Behra, P. K. Vadiraj, A. Venuthurimilli, Shalimar, N. R. Dash, S. R. Gamanagatti, P. K. Garg// Gastrointest.
Endosc. - 2015. -V 81(2). – P. 351–359.121.Di Magno, E.P. Acute pancreatitis. In: Sleisenger & Fortain’s gastrointestinal and liver disease,7th end/ E.P. Di Magno, S. Chari; Ed. by M. Feldman, W.O.J. Tshumy et al.// Philadelfia:Elsevier Sciense, 2002. - 913-942 p.122.aryDing, G. The safety and utility of pancreatic duct stents in the emergency ERCP of acute bilipancreatitisbutdifficultsphincterotomy/G.Ding, M.Qin,W.Cai, F.Zou, H.Zhao//Hepatogastroenterology. – 2012. – V 59 (120).
- P. 2374-6.123.Donnellan, F. Review Article: Prevention of Post- ERCP Pancreatitis [Electronic Resource] / F.Donnellan, M.F. Byrne - Gastroenterology Research and Practice. – 2012. - Режим доступа:122https://www.hindawi.com/journals/grp/2012/796751/ (дата обращения: 12.10.2016).124.Dubravcsik, Z. Early ERCP and biliary sphincterotomy with or without small- caliber pancreat-ic stent insertion in patients with acute biliary pancreatitis: better overall outcome with adequate pa ncreatic drainage/ Z.
Dubravcsik, I. Hritz, R. Fejes, G. Balogh, Z. Virányi, P. Hausinger, A. Székely, A.Szepes, L. Madácsy// Scand. J. Gastroenterol. - 2012. - 47(6). – P. 729-36.125.Dubravcsik, Z. Hungarian Pancreatic Study Group. Preventive pancreatic stents in themanagement of acute biliary pancreatitis (PREPAST trial): pre-study protocol for a multicenter,prospective, randomized, interventional, controlled trial/ Z. Dubravcsik, L. Madácsy, T.
Gyökeres, Á.Vincze, Z. Szepes, P. Hegyi, I. Hritz, A. Szepes// Pancreatology. – 2015. – V 15(2). – P. 115-23.126.Dumonceau,J.M.Prophylaxis of post-ERCPpancreatitis: a practice survey/ J.M.Dumonceau, J. Rigaux, M. Kahaleh, C.M. Gomez, A. Vandermeeren, J. Devière// Gastrointest.
Endosc. – 2010. – N 71. – P. 934–939.127.Dumonceau, J.M. Prophylaxis of post-ERCP pancreatitis: European Society of GastrointestinalEndoscopy (ESGE) Guideline - updated June 2014/ J.M. Dumonceau, A. Andriulli, B.J. Elmunzer, A.Mariani, T. Meister, J. Deviere, T. Marek, T.H. Baron, C. Hassan, P.A.,Testoni, C. Kapral; EuropeanSociety of Gastrointestinal Endoscopy// Endoscopy.
- 2014. – V 46(9). – P. 799-815.128.Dumonceau, J.M. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophy-laxis of post-ERCP pancreatitis/ J.M. Dumonceau, A. Andriulli, Deviere J, A. Mariani, J. Rigaux, T.H.Baron, P.A. Testoni// Endoscopy. – 2010. – V 42 (6) – P. 503–515.129.Duvnjak, M. Use of octreotide-acetate in preventing pancreatitis- like changes following thera-peutic endoscopic retrograde cholangiopancreatography/ M.
Duvnjak, V. Supanc, V.N. Simicevic, D.Hrabar, B. Troskot, L. Smircić-Duvnjak, M. Bekavac-Beslin// Acta Med. Croatica. - 1999. – N 53. – P.115 – 118.130.Elfar, M. The Inflammatory Cascade in Acute Pancreatitis: Relevance to Clinical Disease/M. Elfar, L. W. Gaber, O. Sabek, C. P. Fischer, A. Osama Gaber// Surg.
Clin. N. Am. – 2007. - V87(6) - P. 1325–1340.131.Elmunzer, B.J. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis/B.J. Elmunzer, J.M. Scheiman, G.A. Lehman, A. Chak, P. Mosler, P.D. Higgins, R.A. Hayward, J.Romagnuolo, G.H. Elta, S. Sherman, A.K. Waljee, A. Repaka, M.R. Atkinson, G.A. Cote, R.S.Kwon, L. McHenry, C.R. Piraka, E.J. Wamsteker, J.L. Watkins, S.J. Korsnes, S.E. Schmidt, S.M.Turner,S. Nicholson,E.L. Fogel; U.S.
Cooperative for Outcomes Research in Endoscopy(USCORE)// N. Engl. J. Med. - 2012. - V 366 (15). – P. 1414-22.132.Elmunzer, B.J. Reducing the risk of post-endoscohic retrograde cholangiopancreatog-raphy pancreatitis/ B.J. Elmunzer// Dig. Endosc. – 2017. – V 29(7). – P. 749-757.123133.Elmunzer, B.J. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis/B.J. Elmunzer, A.K. Waljee, G.H. Elta, J.R. Taylor, S.M. Fehmi, P.D. Higgins//Gut. – 2008. – V57(9). – P. 1262–1267.134.Elmunzer, B.J. Does rectal indomethacin eliminate the need for prophylactic pancreatic stentplacement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses usingprospective clinical trial data/ B.J.
Elmunzer, P.D. Higgins, D. Sameer, S.D. Saini, J. M. Scheiman,R.A. Parker, A. Chak, J. Romagnuolo, P. Mosler, R.A. Hayward, G.A. Elta, S. J. Korsnes, S.E.Schmidt, S. S. Sherman, G. A. Lehman, E.L. Fogel//Am. J. Gastroenterol . – 2013. - V 108 (3). –P. 410–5.135.Fan, J.H. Updated meta-analysis of pancreatic stent placement in preventing post-endoscopicretrograde cholangiopancreatography pancreatitis/ J.H.
Fan,J.B. Qian,Y.M. Wang,R.H.Shi, C.J. Zhao//World J. Gastroenterol. - 2015. – V 21(24). – P. 7577-83.136.Fazel, A. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospectiverandomizedstudy/A.Fazel, A.Quadri, M.F.Catalano, S.M.Meyerson, J.E.Geenen//Gastrointest. Endosc. – 2003. – N 57. – P. 291-294.137.Fejes, R. Feasibility and safety of emergency ERCP and small-caliber pancreatic stenting as abridging procedure in patients with acute biliary pancreatitis but difficult sphincterotomy/ R. Fejes, G.Kurucsai, A.
Székely, I. Székely, A. Altorjay, L. Madácsy// Surg. Endosc. – 2010. - V 24(8). – P.1878-85.138.Fogel, E.L. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreaticstent placement has a lower rate of pancreatitis than biliary sphincterotomy alone/ E.L. Fogel, D.Eversman, P. Jamidar, S. Sherman, G.A. Lehman // Endoscopy. – 2002. – N 34. – P. 280–285.139.Foster, E. Pharmacotherapy for the prevention of post-ERCP pancreatitis/ E. Foster, J. Leung//Am. J. Gastroenterol.
- 2007. – N 102. – P. 52-55.140.Freeman, M.L. Complications of endoscopic biliary sphincterotomy/ M.L. Freeman, D.B. Nel-son, S. Sherman, G.B. Haber, M.E. Herman, P.J. Dorsher, J.P. Moore, M.B. Fennerty, M.E.Ryan, M.J. Shaw, J.D. Lande, A.M. Pheley// N. Engl. J. Med. – 1996.